PURPOSE: Nonconvulsive status epilepticus (NCSE) is an under-recognized cause of altered mental status. There are hardly any reported data on NCSE in developing countries. MATERIAL AND METHODS: Prospectively 210 consecutive patients with altered mental status admitted to neurological intensive care unit (NICU) of a tertiary care center in south India were studied for the frequency of NCSE. All patients were evaluated initially with 60-min emergent EEG (EmEEG) and subsequently by continuous EEG (cEEG) monitoring. RESULTS: Of the 210 with altered mental status admitted to NICU, the diagnosis of NCSE was established in 22 (10.5%) patients, in 12 (55%) patients with 60-min EmEEG and in 10 (45%) after cEEG monitoring for 12 to 48 hours. Of the 22 patients with NCSE, 32% had subtle motor phenomena, these were not an initial presenting features, but were apparent during cEEG recording. Acute medical or neurologic etiology was the risk factor in 68% of patients. Central nervous system (CNS) infections and cortical sino-venous thrombosis (CSVT), respectively, accounted for 23% and 14% of the etiologies. Intravenous midazolam terminated NCSE in 19 patients and valproate in 2. Of the 15 patients with acute symptomatic NCSE, 4 (18%) had poor prognosis (3 deaths and one persistent vegetative state). The etiological risk factors in the 9 (41%) patients with excellent outcome included epilepsy (3), remote symptomatic (2), cryptogenic (1), and metabolic and drugs (3). CONCLUSIONS: The frequency of NCSE in the current study was comparable with those in prior reports from developed countries. CNS infections accounted for about a fifth of the etiology. Outcome was excellent in patients with nonacute symptomatic NCSE. Initial 60-min EmEEG may be performed in establishing the diagnosis of NCSE, but almost half of patients with NCSE will be missed with this approach.
PURPOSE:Nonconvulsive status epilepticus (NCSE) is an under-recognized cause of altered mental status. There are hardly any reported data on NCSE in developing countries. MATERIAL AND METHODS: Prospectively 210 consecutive patients with altered mental status admitted to neurological intensive care unit (NICU) of a tertiary care center in south India were studied for the frequency of NCSE. All patients were evaluated initially with 60-min emergent EEG (EmEEG) and subsequently by continuous EEG (cEEG) monitoring. RESULTS: Of the 210 with altered mental status admitted to NICU, the diagnosis of NCSE was established in 22 (10.5%) patients, in 12 (55%) patients with 60-min EmEEG and in 10 (45%) after cEEG monitoring for 12 to 48 hours. Of the 22 patients with NCSE, 32% had subtle motor phenomena, these were not an initial presenting features, but were apparent during cEEG recording. Acute medical or neurologic etiology was the risk factor in 68% of patients. Central nervous system (CNS) infections and cortical sino-venous thrombosis (CSVT), respectively, accounted for 23% and 14% of the etiologies. Intravenous midazolam terminated NCSE in 19 patients and valproate in 2. Of the 15 patients with acute symptomatic NCSE, 4 (18%) had poor prognosis (3 deaths and one persistent vegetative state). The etiological risk factors in the 9 (41%) patients with excellent outcome included epilepsy (3), remote symptomatic (2), cryptogenic (1), and metabolic and drugs (3). CONCLUSIONS: The frequency of NCSE in the current study was comparable with those in prior reports from developed countries. CNS infections accounted for about a fifth of the etiology. Outcome was excellent in patients with nonacute symptomatic NCSE. Initial 60-min EmEEG may be performed in establishing the diagnosis of NCSE, but almost half of patients with NCSE will be missed with this approach.
Authors: Wei-Ting Chiu; Vanessa Campozano; Alois Schiefecker; Dannys Rivero Rodriguez; Daniel Ferreira; Amy Headlee; Sinead Zeidan; Alexandra Grinea; Yao-Hsien Huang; Kevin Doyle; Qi Shen; Diana Gómez; Sara E Hocker; Benjamin Rohaut; Romain Sonneville; Chien-Tai Hong; Sophie Demeret; Pedro Kurtz; Nelson Maldonado; Raimund Helbok; Telmo Fernandez; Jan Claassen Journal: Neurology Date: 2022-08-02 Impact factor: 11.800
Authors: Ikuko Laccheo; Hasan Sonmezturk; Amar B Bhatt; Luke Tomycz; Yaping Shi; Marianna Ringel; Gina DiCarlo; DeAngelo Harris; John Barwise; Bassel Abou-Khalil; Kevin F Haas Journal: Neurocrit Care Date: 2015-04 Impact factor: 3.210
Authors: John M Schreiber; Tesfaye Zelleke; William D Gaillard; Himanshu Kaulas; Nathan Dean; Jessica L Carpenter Journal: Neurocrit Care Date: 2012-08 Impact factor: 3.210
Authors: Shobhit Singla; Gabriella E Garcia; Grace E Rovenolt; Alexandria L Soto; Emily J Gilmore; Lawrence J Hirsch; Hal Blumenfeld; Kevin N Sheth; S Bulent Omay; Aaron F Struck; M Brandon Westover; Jennifer A Kim Journal: Curr Neurol Neurosci Rep Date: 2020-07-27 Impact factor: 6.030